Pediatrics CME

VisualDx is an award-winning clinical decision support system. Your second opinion in your pocket. Designed to support therapeutic decisions and elevate patient satisfaction, it’s a tool clinicians trust every day.

On average, users save over 2 hours a week. VisualDx leverages artificial intelligence to help you quickly analyze skin lesions: snap a photo, match symptoms, and generate a tailored differential diagnosis in seconds. It’s clinical confidence, accelerated.

This exclusive Pediatric & Adolescent Medicine CME Topical Collection offers insights into clinical pharmacology, infectious disease, substance abuse, and much more in this multi-specialty collection.

Stay on top of your game with the StatPearls Physician Unlimited CME programs. With 6,046 activities, StatPearls is the largest CME provider in the world. These Pub-Med Indexed articles are categorized into 162 specialty areas which lets you better access activities that will make the biggest impact on your practice. One subscription allows access to all the activities, including all state-requirements.

Pricing Options

• 6 Month subscription: All 6,339 CME Activities – $249 per 6 months
• Annual subscription: All 6,339 CME Activities – $349 per 1 year
• Lifetime: All 6,339 CME Activities + Access to Board Reviews Forever – $1999

Your MDCalc CME subscription includes 15 AMA PRA Category 1 Credits™, with up to 11.5 credits available in the Pediatrics specialty.

Easily earn and redeem CME as you use review CME eligible calculator content. Over 1 million medical professionals use MDCalc’s over 550 tools daily to support clinical decision making at the bedside. Earn CME with the following Pediatrics calculators:

• AAP Pediatric HTN Guidelines
• Alvarado Score
• APGAR Score
• Bacterial Meningitis Score
• CATCH Rule
• FeverPAIN Score
• Paradise Criteria
• Pediatric Appendicitis Score (PAS)
• Peds NEXUS II Head CT Decision Instrument
• Rule of 7s
• Steroid Conversion
• Westley Croup Score

The BoardVitals Pediatric MOC Question Bank and Recertification Test Prep has over 1400 Pediatric MOC Recertification questions targeted to the ABP exam guidelines. Each question has an answer and detailed explanation, as well as an indicator of the percentage of Pediatricians who answered the question correctly. Like the Pediatric MOC exam itself, the Board Vitals question bank is focused on clinical knowledge.

The BoardVitals Pediatric MOC Question Bank and Recertification Test Prep features:
• Pediatric practice tests in review mode or timed mode
• Individually suggested content based on your strengths and weaknesses using Computer Adaptive Testing
• Each question is reviewed and rated by other Pediatricians
Pediatricians preparing for initial certification should see the Board Vitals Pediatrics Board Review Question Bank and Study Program.

Target Audience:
Pediatricians preparing for the Maintenance of Certification exam.

Attention-deficit/hyperactivity disorder (ADHD) is a chronic neurodevelopmental disorder that has been diagnosed in up to 10% of school-age children in the US and frequently persists into adulthood. A study in a large Danish cohort found that ADHD was associated with higher mortality rates in children, adolescents, and adults, mainly due to accidents. Pharmacologic treatment of ADHD in children has been reported to decrease the risk of substance abuse in adolescents, and use of ADHD medications in adults has been associated with a reduced risk of serious traffic accidents and criminal behavior. This activity discusses how to reduce the risk of ADHD with PTBM and drugs approved by the FDA for treatment of ADHD.

In this online, self-learning activity:

IgA nephropathy (IgAN) is an inflammatory kidney disease with IgA deposition in the glomerular mesangium. IgAN is the most prevalent primary chronic glomerular disease worldwide. Globally, IgAN has an estimated incidence of 25 cases per one million people annually. It is more common in children and young adults than in the elderly. Among patients of all ages, the average annual prevalence of IgAN in the United States is 329 per 1 million. The epidemiology and gender distribution of IgAN vary by country and region. In North America and Europe, the prevalence is higher in men.

Target Audience:

HCPs including: nephrologists, internists, and pediatricians; physician associates, nurse practitioners, and pharmacists who practice in those areas of specialty; and those who otherwise care for or clinically encounter patients with IgAN.

In this online, self-learning activity:

Alpha-mannosidosis (AM) is a rare recessive lysosomal storage disorder characterized by immune deficiency, facial and skeletal abnormalities, hearing impairment, and intellectual disability. It is caused by mutations in the MAN2B1 gene, leading to deficiency in alpha-mannosidase, a lysosomal enzyme involved in the oligosaccharide degradation pathway. While the exact prevalence of AM in the US is unknown, it has an estimated incidence of 1 in 500,000 live births worldwide. Laboratory indicators of AM often appear shortly after birth, followed by progression of clinical manifestations. While symptoms of AM vary considerably in individual presentations, three clinical subtypes have been identified (mild, moderate, and severe) and are used to guide disease prognosis and management. The current diagnostic algorithm for AM focuses on measuring alpha-mannosidase activity in leukocytes using colorimetry or fluorimetry. An alpha-mannosidase activity level of under 5% suggests AM, and a diagnosis is then confirmed with genetic sequencing.

Activity Description / Statement of Need:

In this online, self-learning activity:

Thymidine kinase 2 deficiency (TK2D) is an ultrarare mitochondrial disease caused by recessive mutations in the TK2 gene and manifesting as a form of mitochondrial DNA depletion/deletion syndrome (MDDS) and mitochondrial myopathy. Under normal conditions, the TK2 gene encodes for the thymidine kinase enzyme present in the mitochondria, which is responsible for the phosphorylating of pyrimidine nucleosides, deoxythymidine, and deoxycytidine. These are the first steps in mitochondrial DNA synthesis, and researchers speculate that TK2 mutations affect muscle tissue because its higher energy demands make it most susceptible to mitochondrial impairment. Mutational analyses of patients with MDDS have found that approximately 15% have TK2 mutations, which may be extrapolated to about 600 to 2,700 individuals in the US.

Target Audience:

HCPs including but not limited to: neurologists, pediatric neurologists, pediatricians, primary care providers, pulmonologists, gastroenterologists, and medical geneticists; physician assistants, nurse practitioners, pharmacists, and nurses who practice in the aforementioned areas of specialty; and any other HCPs with an interest in or who may clinically encounter patients with TK2D.

In this online, self-learning activity:

Crohn’s disease (CD) is an inflammatory bowel disease (IBD) defined by a transmural process that often occurs in the terminal ileum; although, any portion of the gastrointestinal (GI) tract can be affected. While the exact etiology of CD is unknown, a handful of genetic, immunologic, and environmental risk factors have been identified, including an impaired immune response to commensal or pathogenic intestinal microbiota that drives mucosal inflammation in genetically susceptible patients. About 34,000 children in the United States have CD, and the incidence of pediatric CD has increased by about 10% annually since 2007.

Target Audience:

HCPs including: pediatricians, pediatric gastroenterologists, and those who specialize in adolescent medicine; physician assistants, nurse practitioners, and pharmacists; and any other healthcare professionals with an interest in or who clinically encounter patients with pediatric CD.

The course introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses various aspects of medical marijuana, including administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions.

The use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients is discussed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are also provided.

CBD in Clinical Care provides information that will assist clinicians in effectively treating and counseling cannabidiol (CBD) consumers. The physiological effects of CBD, CBD drug interactions, CBD’s side effects, and the conditions for which CBD has been shown by evidence-based clinical studies to be efficacious are all discussed in this course.

The New York Medical Cannabis Program Required Course Bundle has been approved by the New York State Office of Cannabis Management and satisfies the New York educational requirements to become a practitioner with the New York Medical Cannabis Program.

This bundle introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses various aspects of medical marijuana, including administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions.

The use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients is discussed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided.

The New York State Medical Cannabis Program Rules and Regulations are outlined in a state-specific course, as well.

The Ohio Healthcare Provider Medical Marijuana Course Bundle for Certification (or maintenance of the CTR) is certified by the Ohio State Medical Association and satisfies the CME requirements for the initial Ohio Certificate to Recommend (CTR) application or for maintenance of the CTR.

This bundle introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses various aspects of medical marijuana, including administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions.

The use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients is discussed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided.

The Ohio Medical Marijuana Control Program rules and regulations are outlined in a state-specific course, as well.

The Pennsylvania Medical Marijuana Program Required Course Bundle has been approved by the Pennsylvania Department of Health and satisfies the Pennsylvania educational requirements to become a practitioner with the Pennsylvania Medical Marijuana Program.

This bundle introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses various aspects of medical marijuana, including administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions.

The use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients is discussed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided.

This course bundle also addresses the use of cannabidiol (CBD) in clinical care, and the information will assist clinicians in effectively treating and counseling CBD consumers. The physiological effects of CBD, CBD drug interactions, CBD’s side effects, and the conditions for which CBD has been shown by evidence-based clinical studies to be efficacious are all discussed in this course bundle.

The Pennsylvania Medical Marijuana Program rules and regulations are outlined in a state-specific course, as well.

The Utah Medical Cannabis Program Required Course Bundle has been approved by the Utah Department of Health and satisfies the Utah educational requirements to become a practitioner with the Utah Medical Cannabis Program.

The Utah Medical Cannabis Program Required Course Bundle introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions.

The use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients is discussed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided.

This course bundle also provides information that assists clinicians in effectively treating and counseling CBD consumers.

The West Virginia Medical Cannabis Program Required Course Bundle has been approved by the West Virginia Department of Health and Human Resources, Bureau for Public Health, Office of Medical Cannabis and satisfies the West Virginia educational requirements to become a practitioner with the West Virginia Medical Cannabis Program.

This course introduces the reader to the endocannabinoid system and its interaction with the components of the cannabis plant, and addresses administration, therapeutic use, drug metabolism, physiologic and cognitive effects, potential risks, and drug interactions.

The use of marijuana in obstetric patients, pediatric patients, adolescent patients and elderly patients is discussed in detail. Important considerations for patients with ischemic heart disease, hepatic disease, psychotic illness, and those with a history of drug dependence are provided.

This course bundle also addresses the use of cannabidiol (CBD) in clinical care, and the information will assist clinicians in effectively treating and counseling CBD consumers. The physiological effects of CBD, CBD drug interactions, CBD’s side effects, and the conditions for which CBD has been shown by evidence-based clinical studies to be efficacious are all discussed in this course bundle.

The West Virginia medical cannabis program rules and regulations are outlined in a state-specific course, as well.

The West Virginia medical cannabis program rules and regulations are outlined in a state-specific course, as well.

Level Up Your Diagnostic Skills with the ImageSim Pediatric Skull Radiograph Course. Step into the role of the clinician with 200 real pediatric skull radiographs in a high-impact, interactive diagnostic experience. Developed by world-renowned leaders in radiology, emergency medicine, pediatrics, user design, and medical education, this course offers a cutting-edge learning platform designed for clinicians who demand excellence. Each case presents a concise clinical scenario, challenging you to “make the call” on whether a fracture is present. If you say yes, you’ll need to pinpoint the fracture location. Immediate feedback after every case keeps you sharp and accelerates your learning.

The goal? Mastery at 85% accuracy—a benchmark that ensures real-world confidence and performance. Perfect for physicians and allied health professionals who practice in emergency medicine, pediatrics, radiology, family medicine, child protection, and neurosurgery, this course will elevate your interpretive skills and clinical decision-making on one of the most critical and commonly misinterpreted radiographs in pediatric practice.

Level Up Your Diagnostic Skills with the ImageSim Pediatric Clavicle/Shoulder/Humerus Radiograph Course. Step into the role of the clinician with 300 real pediatric clavicle/shoulder/humerus radiographs in a high-impact, interactive diagnostic experience. Developed by world-renowned leaders in radiology, orthopedics, emergency medicine, pediatrics, user design, and medical education, this course offers a cutting-edge learning platform designed for clinicians who demand excellence. Each case presents a concise clinical scenario, challenging you to “make the call” on whether a fracture is present. If you say yes, you’ll need to pinpoint the fracture location.

Immediate feedback after every case keeps you sharp and accelerates your learning. The goal? Mastery at 85% accuracy—a benchmark that ensures real-world confidence and performance. Perfect for physicians and allied health professionals in emergency medicine, pediatrics, radiology, orthopedics, and family medicine, this course will elevate your interpretive skills and clinical decision-making on one of the most critical and commonly misinterpreted radiographs in pediatric practice.